190 related articles for article (PubMed ID: 25932121)
1. A modified porous tantalum implant technique for osteonecrosis of the femoral head: survivorship analysis and prognostic factors for radiographic progression and conversion to total hip arthroplasty.
Liu Y; Su X; Zhou S; Wang L; Wang C; Liu S
Int J Clin Exp Med; 2015; 8(2):1918-30. PubMed ID: 25932121
[TBL] [Abstract][Full Text] [Related]
2. Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty.
Liu Y; Yan L; Zhou S; Su X; Cao Y; Wang C; Liu S
Int Orthop; 2016 Jul; 40(7):1397-407. PubMed ID: 26257275
[TBL] [Abstract][Full Text] [Related]
3. [A modified porous tantalum implant technology for osteonecrosis of the femoral head: survival and prognostic evaluations of conversion into total hip arthroplasty].
Liu Y; Liu S; Zhou S; Su X; Wang C; Cao Y; Jiang W; Cui Q; Wang L
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2429-33. PubMed ID: 25400049
[TBL] [Abstract][Full Text] [Related]
4. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head.
Veillette CJ; Mehdian H; Schemitsch EH; McKee MD
J Bone Joint Surg Am; 2006 Nov; 88 Suppl 3():48-55. PubMed ID: 17079367
[TBL] [Abstract][Full Text] [Related]
5. Porous Tantalum Implant in Treating Osteonecrosis of the Femoral Head: Still a Viable Option?
Ma J; Sun W; Gao F; Guo W; Wang Y; Li Z
Sci Rep; 2016 Jun; 6():28227. PubMed ID: 27324659
[TBL] [Abstract][Full Text] [Related]
6. Modified porous tantalum rod technique for the treatment of femoral head osteonecrosis.
Pakos EE; Megas P; Paschos NK; Syggelos SA; Kouzelis A; Georgiadis G; Xenakis TA
World J Orthop; 2015 Nov; 6(10):829-37. PubMed ID: 26601065
[TBL] [Abstract][Full Text] [Related]
7. Porous tantalum rod implantation is associated with low survival rates in patients with type C2 osteonecrosis of the femoral head but has no effect on the clinical outcome of conversion total hip arthroplasty: a retrospective study with an average 8-year follow-up.
He M; Wei Q; Chen Z; Yang F; Chen X; Qin YX; Fang B; He W
BMC Musculoskelet Disord; 2020 Dec; 21(1):841. PubMed ID: 33308229
[TBL] [Abstract][Full Text] [Related]
8. Porous tantalum implant for treatment of early-stage osteonecrosis of the femoral head: a minimum 5-year follow-up study.
Zhang Y; Chen W; Yang Z; Sun JN; Hu ZH; Hua ZJ; Chen XY; Feng S
BMC Surg; 2021 Oct; 21(1):360. PubMed ID: 34627202
[TBL] [Abstract][Full Text] [Related]
9. Total hip arthroplasty following failure of tantalum rod implantation for osteonecrosis of the femoral head with 5- to 10-year follow-up.
Cheng Q; Tang JL; Gu JJ; Guo KJ; Guo WS; Wang BL; Zhao FC
BMC Musculoskelet Disord; 2018 Aug; 19(1):289. PubMed ID: 30115057
[TBL] [Abstract][Full Text] [Related]
10. Core Decompression with Local Administration of Zoledronate and Enriched Bone Marrow Mononuclear Cells for Treatment of Non-Traumatic Osteonecrosis of Femoral Head.
Ma HY; Ma N; Liu YF; Wan YQ; Liu GQ; Liu GB; Meng HY; Li H; Wang X; Li CB; Peng J
Orthop Surg; 2021 Aug; 13(6):1843-1852. PubMed ID: 34664417
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head.
Zhao D; Liu B; Wang B; Yang L; Xie H; Huang S; Zhang Y; Wei X
Biomed Res Int; 2015; 2015():240506. PubMed ID: 25802840
[TBL] [Abstract][Full Text] [Related]
12. Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip: A Prospective Study.
Houdek MT; Wyles CC; Collins MS; Howe BM; Terzic A; Behfar A; Sierra RJ
Clin Orthop Relat Res; 2018 Feb; 476(2):388-397. PubMed ID: 29529674
[TBL] [Abstract][Full Text] [Related]
13. Outcome after a new porous tantalum rod implantation for treatment of early-stage femoral head osteonecrosis.
Huang W; Gong X; Sandiford S; He X; Li F; Li Y; Liu Z; Qin L; Yang J; Zhu S; Wang J; Tu X; Ye L; Hu N
Ann Transl Med; 2019 Sep; 7(18):441. PubMed ID: 31700877
[TBL] [Abstract][Full Text] [Related]
14. Real-time computerised tomography assisted porous tantalum implant in ARCO stage I-II non-traumatic osteonecrosis of the femoral head: minimum five-year follow up.
Hu R; Lei P; Li B; Liu H; Yang X; Wen T; Hu Y; Tian X
Int Orthop; 2018 Jul; 42(7):1535-1544. PubMed ID: 29589085
[TBL] [Abstract][Full Text] [Related]
15. Hip decompression combined with bone marrow concentrate and platelet-rich plasma for corticosteroid-induced osteonecrosis of the femoral head : mid-term update from a prospective study.
Houdek MT; Wyles CC; Smith JH; Terzic A; Behfar A; Sierra RJ
Bone Jt Open; 2021 Nov; 2(11):926-931. PubMed ID: 34751583
[TBL] [Abstract][Full Text] [Related]
16. Porous tantalum rods for treating osteonecrosis of the femoral head.
Liu ZH; Guo WS; Li ZR; Cheng LM; Zhang QD; Yue DB; Shi ZC; Wang BL; Sun W; Zhang NF
Genet Mol Res; 2014 Oct; 13(4):8342-52. PubMed ID: 25366728
[TBL] [Abstract][Full Text] [Related]
17. Core decompression vs. allogenic non-vascularized bone grafting in patients with osteonecrosis of the femoral head.
Mei J; Jiang ZP; Pang LL; Huang Y; Gong Y; Zhu J; Zhang LW
Front Surg; 2023; 10():1219835. PubMed ID: 37711137
[TBL] [Abstract][Full Text] [Related]
18. Results of Total Hip Arthroplasty after Core Decompression with Tantalum Rod for Osteonecrosis of the Femoral Head.
Lee GW; Park KS; Kim DY; Lee YM; Eshnazarov KE; Yoon TR
Clin Orthop Surg; 2016 Mar; 8(1):38-44. PubMed ID: 26929797
[TBL] [Abstract][Full Text] [Related]
19. What is the rate of patients undergoing a total hip arthroplasty after core decompression and insertion of a tantalum rod in osteonecrosis of the femoral head: a systematic review.
Aurégan JC; Villain B; Bégué T
Int Orthop; 2018 Jul; 42(7):1631-1638. PubMed ID: 29728733
[TBL] [Abstract][Full Text] [Related]
20. Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.
Varitimidis SE; Dimitroulias AP; Karachalios TS; Dailiana ZH; Malizos KN
Acta Orthop; 2009 Feb; 80(1):20-5. PubMed ID: 19297785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
